Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kaynoosh Homayouni, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01680263
First received: July 13, 2012
Last updated: September 3, 2012
Last verified: September 2012
  Purpose

The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.


Condition Intervention
Pes Anserinus Tendinobursitis
Device: Kinesiotaping
Procedure: NSAIDs/Physical therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis

Resource links provided by NLM:


Further study details as provided by Shiraz University of Medical Sciences:

Primary Outcome Measures:
  • Pain (VAS)and swelling scores [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]
    Visual analog scale for pain evaluation Assessment of the local swelling via palpation


Secondary Outcome Measures:
  • The number of participants with adverse events [ Time Frame: 3 weeks ] [ Designated as safety issue: Yes ]
    The number of participants with adverse events


Enrollment: 46
Study Start Date: February 2012
Study Completion Date: July 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Kinesiotaping
Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1 week interval
Device: Kinesiotaping
Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval
Other Name: taping
Active Comparator: NSAIDs/Physical therapy
treatment was done with NSAIDs and 10 sessions of daily physical therapy.
Procedure: NSAIDs/Physical therapy
Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.
Other Names:
  • non-steroidal anti-inflammatory drugs
  • physical therapy

Detailed Description:

The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with clinical diagnosis of pes anserinus tendino-bursitis.

Exclusion Criteria:

  • Previous history of trauma or surgery on the knee joint,
  • History of NSAIDs induced acid-peptic disease
  • Systemic and rheumatic diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01680263

Locations
Iran, Islamic Republic of
Shiraz University of Medical Sciences
Shiraz, Fars, Iran, Islamic Republic of
Sponsors and Collaborators
Shiraz University of Medical Sciences
Investigators
Study Chair: Kaynoosh Homayouni, M.D. Shiraz University of Medical Sciences
Principal Investigator: Shima Foruzi, M.D. Shiraz University of Medical Sciences
Principal Investigator: Fereshte Kalhori, M.D. Shiraz University of Medical Sciences
  More Information

No publications provided

Responsible Party: Kaynoosh Homayouni, Assistant professor of Physical Medicine and Rehabilitation, Shiraz University of Medical Sciences
ClinicalTrials.gov Identifier: NCT01680263     History of Changes
Other Study ID Numbers: K Homayouni
Study First Received: July 13, 2012
Last Updated: September 3, 2012
Health Authority: Iran: Shiraz University of Medical Sciences

Keywords provided by Shiraz University of Medical Sciences:
Kinesiotaping
pes anserinus tendino-bursitis
nonsteroidal anti-inflammatory drugs
physical therapy

Additional relevant MeSH terms:
Bursitis
Joint Diseases
Musculoskeletal Diseases
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Analgesics
Analgesics, Non-Narcotic
Antirheumatic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on November 27, 2014